FAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition

Symeonides, S; Evans, TRJ; Coyle, V; Serrels, A; Thomson, F; Currie, D; Dillon, S; Paul, J; Fennell, DA; Ottensmeier, C

ANNALS OF ONCOLOGY, 2017; 28 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索